Comparison of the inhibitions of proliferation of normal and psoriatic fibroblasts by 1 alpha,25-dihydroxyvitamin D3 and synthetic analogues of vitamin D3 with an oxygen atom in their side chain
- PMID: 2561444
Comparison of the inhibitions of proliferation of normal and psoriatic fibroblasts by 1 alpha,25-dihydroxyvitamin D3 and synthetic analogues of vitamin D3 with an oxygen atom in their side chain
Abstract
The inhibitory effects of 1 alpha,25-(OH)2D3 and synthetic oxa-derivatives of vitamin D3 on growth of normal and psoriatic fibroblasts in culture were compared. Proliferation of normal fibroblasts was strongly inhibited by these new compounds in the following order: 22-oxa-1 alpha,25-(OH)2D3 greater than 22-oxa-1 alpha-(OH)D3 greater than 1 alpha,25-(OH)2D3 greater than 20-oxa-1 alpha,25-(OH)2D3. 22-Oxa-1 alpha,25-(OH)2D3 was about 10-times more inhibitory than 1 alpha,25-(OH)2D3. Proliferation of psoriatic fibroblasts was not inhibited by 1 alpha,25-(OH)2D3 at concentrations of up to 10(-6) M, but was suppressed by 10(-8)-10(-6) M 22-oxa-1 alpha,25-(OH)2D3 and 10(-6) M 22-oxa-1 alpha-(OH)D3. These results suggest that oxa-derivatives of vitamin D3, especially 22-oxa-1 alpha,25-(OH)2D3, should be useful in further studies on the cause and treatment of psoriasis.
Similar articles
-
Effects of 1,25-dihydroxyvitamin D3 and its 20-epi analogues (MC 1288, MC 1301, KH 1060), on clonal keratinocyte growth: evidence for differentiation of keratinocyte stem cells and analysis of the modulatory effects of cytokines.Br J Pharmacol. 1997 Mar;120(6):1119-27. doi: 10.1038/sj.bjp.0701015. Br J Pharmacol. 1997. PMID: 9134225 Free PMC article.
-
Hybrid structural analogues of 1,25-(OH)2D3 regulate chondrocyte proliferation and proteoglycan production as well as protein kinase C through a nongenomic pathway.J Cell Biochem. 1997 Sep 15;66(4):457-70. J Cell Biochem. 1997. PMID: 9282324
-
A synthetic analogue of vitamin D3, 22-oxa-1 alpha,25-dihydroxyvitamin D3, is a potent modulator of in vivo immunoregulating activity without inducing hypercalcemia in mice.Endocrinology. 1989 May;124(5):2645-7. doi: 10.1210/endo-124-5-2645. Endocrinology. 1989. PMID: 2539984
-
1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.Dan Med Bull. 2008 Nov;55(4):186-210. Dan Med Bull. 2008. PMID: 19232159 Review.
-
Systemic effects of vitamin D.Annu Rev Med. 1989;40:71-8. doi: 10.1146/annurev.me.40.020189.000443. Annu Rev Med. 1989. PMID: 2658762 Review.
Cited by
-
Vitamin D endocrine system and osteoclasts.Bonekey Rep. 2014 Feb 5;3:495. doi: 10.1038/bonekey.2013.229. eCollection 2014. Bonekey Rep. 2014. PMID: 24605212 Free PMC article.
-
Pathogenesis of Systemic Sclerosis.Front Immunol. 2015 Jun 8;6:272. doi: 10.3389/fimmu.2015.00272. eCollection 2015. Front Immunol. 2015. PMID: 26106387 Free PMC article. Review.
-
Eldecalcitol is more effective in promoting osteogenesis than alfacalcidol in Cyp27b1-knockout mice.PLoS One. 2018 Oct 3;13(10):e0199856. doi: 10.1371/journal.pone.0199856. eCollection 2018. PLoS One. 2018. PMID: 30281599 Free PMC article.
-
A vitamin D analog ameliorates glomerular injury on rat glomerulonephritis.Am J Pathol. 2001 May;158(5):1733-41. doi: 10.1016/S0002-9440(10)64129-6. Am J Pathol. 2001. PMID: 11337371 Free PMC article.
-
Vitamin D and its analogs in chronic renal failure.Osteoporos Int. 1997;7 Suppl 3:S202-8. doi: 10.1007/BF03194373. Osteoporos Int. 1997. PMID: 9536333 Review. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical